1-3 of 3
Morten Kranker Larsen
Close
Sort by
Journal Articles

CHIP- JAK2V617F , chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties

Hans Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
Journal: Blood Advances
Blood Adv (2024) 8 (3): 681–682.
https://doi.org/10.1182/bloodadvances.2023012190
Published: 2024
Journal Articles

JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study

Marie Hvelplund Kristiansen, Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Hans Carl Hasselbalch, Troels Wienecke
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5825–5834.
https://doi.org/10.1182/bloodadvances.2023010588
Published: 2023
Includes: Supplemental data
Journal Articles

The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment

Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Lee O'Brien Andersen, Henrik V. Nielsen, Kurt Fuursted, Christen Rune Stensvold, Morten Kranker Larsen, Lasse Kjær, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Christina Ellervik, Lars Rønn Olsen, Hans Carl Hasselbalch, Xiaohui Chen Nielsen, Jens Jørgen Elmer Christensen
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3326–3337.
https://doi.org/10.1182/bloodadvances.2022008555
Published: 2023
Includes: Supplemental data